Physician profile
Amanda L Witt
NPI 1386840619
$46,727.12
in general payments reported to CMS, 2019-2025
44 companies · $1,262 in 2025
The $1,262 reported for 2025 was more than what 81% of Neuromuscular Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $128).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $20K · 2021: $10K · 2022: $2,275 · 2023: $708 · 2024: $841 · 2025: $1,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,759 · Education: $51.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,758.75 |
| Education | $51.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $41,994.07 | 2019-2025 | Spinraza, Skyclarys, Qalsody |
| Csl Behring | $932.98 | 2019-2025 | Hizentra |
| Alexion Pharmaceuticals, INC. | $923.32 | 2019-2025 | Ultomiris |
| Ucb, INC. | $429.35 | 2020-2025 | Rystiggo, Zilbrysq, Fintepla |
| Argenx US, INC. | $159.44 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Itf Therapeutics LLC | $158.72 | 2024-2025 | |
| Piramal Critical Care | $133.75 | 2019-2025 | |
| Catalyst Pharmaceuticals, INC. | $131.69 | 2024-2025 | |
| Allergan, INC. | $122.97 | 2019-2022 | |
| Tanabe Pharma America, INC. | $118.65 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $111.64 | 2020-2022 | |
| Strongbridge US INC. | $103.21 | 2019-2020 | |
| Amylyx Pharmaceuticals, INC. | $100.71 | 2023-2024 | Relyvrio |
| Abbvie INC. | $95.51 | 2023-2025 | Botox |
| Sarepta Therapeutics, INC. | $86.83 | 2023-2025 | Elevidys |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Witt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.